Skip to main content

CORRECTION article

Front. Med., 23 November 2022
Sec. Intensive Care Medicine and Anesthesiology
Volume 9 - 2022 | https://doi.org/10.3389/fmed.2022.1094735

Corrigendum: Methylene blue dosing strategies in critically ill adults with shock—A retrospective cohort study

This article is a correction to:

  1. Methylene blue dosing strategies in critically ill adults with shock—A retrospective cohort study

    1. Read original article
\nSibel Sari-YavuzSibel Sari-Yavuz1Ka-Lin Heck-SwainKa-Lin Heck-Swain1Marius KellerMarius Keller1Harry MaguniaHarry Magunia1You-Shan FengYou-Shan Feng2Helene A. HaeberleHelene A. Haeberle1Petra WiedPetra Wied1Christian SchlensakChristian Schlensak3Peter RosenbergerPeter Rosenberger1Michael Koeppen Michael Koeppen1*
  • 1Department of Anesthesiology and Intensive Care Medicine, University Hospital Tübingen, Tübingen, Germany
  • 2Institute for Clinical Epidemiology and Applied Biostatistics (IKEaB), Eberhard-Karls-University Tübingen, Tübingen, Germany
  • 3Department of Thoracic and Cardiovascular Surgery, University Hospital Tübingen, Tübingen, Germany

A corrigendum on
Methylene blue dosing strategies in critically ill adults with shock—A retrospective cohort study

by Sari-Yavuz, S., Heck-Swain, K.-L., Keller, M., Magunia, H., Feng, Y.-S., Haeberle, H. A., Wied, P., Schlensak, C., Rosenberger, P., and Koeppen, M. (2022). Front. Med. 9:1014276. doi: 10.3389/fmed.2022.1014276

In the published article, there was an error. The dosing of the continuous infusion of methylene blue is incorrect. Currently the text states “continuous infusion with 0.25 mg/kg/min” this should be changed to “continuous infusion with 0.25 mg/kg/h”.

A correction has been made to Methods, Methylene blue therapy, second paragraph. This sentence previously stated:

“Three different dosing strategies have been used in our institution in the past: bolus injection alone, continuous infusion without bolus, injection, or bolus injection followed by continuous infusion (bolus 2 mg/kg; continuous infusion with 0.25 mg/kg/min).”

The corrected sentence appears below:

“Three different dosing strategies have been used in our institution in the past: bolus injection alone, continuous infusion without bolus, injection, or bolus injection followed by continuous infusion (bolus 2 mg/kg; continuous infusion with 0.25 mg/kg/h).”

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher's note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Keywords: shock, methylene blue, critical care, retrospective study, clinical trial

Citation: Sari-Yavuz S, Heck-Swain K-L, Keller M, Magunia H, Feng Y-S, Haeberle HA, Wied P, Schlensak C, Rosenberger P and Koeppen M (2022) Corrigendum: Methylene blue dosing strategies in critically ill adults with shock—A retrospective cohort study. Front. Med. 9:1094735. doi: 10.3389/fmed.2022.1094735

Received: 10 November 2022; Accepted: 14 November 2022;
Published: 23 November 2022.

Edited and reviewed by: Pavel Michalek, General University Hospital in Prague, Czechia

Copyright © 2022 Sari-Yavuz, Heck-Swain, Keller, Magunia, Feng, Haeberle, Wied, Schlensak, Rosenberger and Koeppen. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Michael Koeppen, bWljaGFlbC5rb2VwcGVuJiN4MDAwNDA7bWVkLnVuaS10dWViaW5nZW4uZGU=

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.